ABOUT
ESPE
Announcements
Mission, Vision/ Impact Statements
Governance
Organisation
Vacancies
Volunteer with ESPE
MEMBERSHIP
Membership Overview
Membership Application
Benefits
Eligibility
Fees
Members area support
EVENTS
The 62nd Annual ESPE Meeting 2024
Upcoming Events
Past Annual ESPE Meetings
CLINICAL PRACTICE
Clinical practice activities
ESPE Funding
EDUCATION
ESPE Connect Webinar Series
E-learning
ESPE Schools
ESPE Science Symposium
ASPED-ESPE Endocrine Academy
Joint EASD/ISPAD/ESPE Postgraduate Education Course
PETCA
European Training Syllabus
GRANTS & AWARDS
Awards
Grants
ESPE Meeting Grants/Awards
Award Winner Gallery
PUBLICATIONS
Newsletter
President Updates
Annual Review
Yearbook
Hormone Research in Paediatrics
Consensus Statement and Guidelines
Patient Booklets
COVID-19 Information Hub
MEMBERS
✕
Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years’ Experience from the PATRO Children Study
Home
Abstracts
Safety and Effectiveness of Omnitrope®, a Biosimilar Recombinant Human Growth Hormone: More Than 10 Years’ Experience from the PATRO Children Study
Share
0
This website uses cookies to improve your experience. By using this website you agree to our
Data Protection Policy
.
Read more
Accept all
